Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Collaboration: Page 3
Oxford Nanopore collaboration makes classroom DNA sequencing accessible
By
Matt Limb
An ambition to make in-classroom DNA sequencing routinely available, more user-friendly, and more egalitarian in U.S. universities and schools has been set out by a leading genetics educator.
October 9, 2023
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
By
LabPulse.com staff writers
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
By
Nick Paul Taylor
Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.
September 6, 2023
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Ginkgo Bioworks, Google Cloud to collaborate on AI tools
By
Matt Limb
Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.
September 6, 2023
Oxford Nanopore, IQVIA form nanopore sequencing partnership
By
Matt Limb
Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.
August 31, 2023
CrisprBits, MolBio Diagnostics to collaborate on POC tests
By
LabPulse.com staff writers
The collaboration will leverage CrisprBits’ expertise in biotechnology and MolBio’s translation, manufacturing, and distribution abilities to build POC tests that detect pathogens and genetic markers.
August 23, 2023
Visiopharm, Boston Cell Standards team up to support higher assay requirements
By
Nick Paul Taylor
If the higher standards are enforced, the collaboration could help enable a revised approach to the regulation of IHC that is intended to increase standardization through the use of modern clinical laboratory quality assurance protocols.
August 17, 2023
Amoy Diagnostics, AstraZeneca partner on CDx for lung cancer therapy
By
LabPulse.com staff writers
This agreement is the latest in ongoing collaborations to develop and commercialize AmoyDx assays for companion diagnostic use with AstraZeneca's prostate, breast, and ovarian cancer therapies.
August 16, 2023
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
By
Matt Limb
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Illumina inks deal to sell Pillar Biosciences’ cancer assays
By
Nick Paul Taylor
Pillar, which has partnerships with Beckman Coulter Life Sciences and Labcorp, designed its NSCLC and CRC panel to run on the Illumina MiSeq Dx instrument. The instrument is a next-generation sequencing (NGS) platform for in vitro diagnostic testing.
July 26, 2023
AccuStem Sciences and EmeritusDX team up on breast cancer assay, product portfolio
By
Matt Limb
Initially, the partnership will focus on furthering the validation of StemPrintER, AccuStem’s recurrence predictor assay for patients with breast cancer.
July 19, 2023
Previous Page
Page 3 of 40
Next Page